| Goris, A and Pauwels, I and Gustavsen, MW and van Son, B and Hilven, K and Bos, SD and Celius, EG and Berg-Hansen, P and Aarseth, J and Myhr, KM and D'Alfonso, S and Barizzone, N and Leone, MA and Boneschi, FM and Sorosina, M and Liberatore, G and Kockum, I and Olsson, T and Hillert, J and Alfredsson, L and Bedri, SK and Hemmer, B and Buck, D and Berthele, A and Knier, B and Biberacher, V and van Pesch, V and Sindi, C and Oturai, AB and Sondergaard, HB and Sellebjerg, F and Jensen, PEH and Comabella, M and Montalban, X and Perez-Boza, J and Malhotra, S and Lechner-Scott, J and Broadley, S and Slee, M and Taylor, B and Kermode, AG and Gourraud, PA and Sawcer, SJ and Andreassen, BK and Dubois, B and Harbo, HF, International Multiple Sclerosis Genetics Consortium, “Genetic variants are major determinants of CSF antibody levels in multiple sclerosis”, Brain, 138 (3) pp. 632-643. ISSN 0006-8950 (2015) [Refereed Article] |
